Cargando…
Selective androgen receptor modulators for the treatment of late onset male hypogonadism
Several testosterone preparations are used in the treatment of hypogonadism in the ageing male. These therapies differ in their convenience, flexibility, regional availability and expense but share their pharmacokinetic basis of approval and dearth of long-term safety data. The brevity and relativel...
Autores principales: | Coss, Christopher C, Jones, Amanda, Hancock, Michael L, Steiner, Mitchell S, Dalton, James T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955335/ https://www.ncbi.nlm.nih.gov/pubmed/24407183 http://dx.doi.org/10.4103/1008-682X.122339 |
Ejemplares similares
-
Commentary on “Late-onset hypogonadism - beyond testosterone”
por: Hackett, Geoffrey
Publicado: (2015) -
Late-onset hypogonadism: Current concepts and controversies of pathogenesis, diagnosis and treatment
por: Huhtaniemi, Ilpo
Publicado: (2014) -
Who are the fair candidates for testosterone replacement therapy in patients with late-onset hypogonadism symptoms?
por: Amano, Toshiyasu
Publicado: (2023) -
Plasma miRNA expression profile in the diagnosis of late-onset hypogonadism
por: Russell, Nicholas, et al.
Publicado: (2016) -
Androgen Receptor CAG Repeat Length as a Risk Factor of Late-Onset Hypogonadism in a Korean Male Population
por: Kim, Jong Wook, et al.
Publicado: (2018)